Effectiveness of Topical 0.5% Levofloxacin to Reduce the Conjunctival Bacterial Flora Before Intraocular Surgery
This study has been completed.
Sponsor:
Ludwig-Maximilians - University of Munich
Collaborator:
Santen Gmbh
Information provided by:
Ludwig-Maximilians - University of Munich
ClinicalTrials.gov Identifier:
NCT00491049
First received: June 21, 2007
Last updated: NA
Last verified: June 2007
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine whether additional topical application of 0.5% levofloxacin is more effective in reducing the load of the conjunctival bacterial flora in patients scheduled for intraocular surgery than preoperative irrigation of the conjunctiva with povidone iodine alone.
| Condition | Intervention | Phase |
|---|---|---|
|
Conjunctival Bacterial Flora |
Drug: 0.5% levofloxacin eye drops |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double-Blind Primary Purpose: Prevention |
| Official Title: | Phase 4 Study on Effectiveness of Topical 0.5% Levofloxacin on Reduction of Preoperative Conjunctival Flora in Patients Scheduled for Intraocular Surgery |
Resource links provided by NLM:
Further study details as provided by Ludwig-Maximilians - University of Munich:
Primary Outcome Measures:
- Rate of culture positive results in thioglycolate broth from conjunctival swabs at defined time points [ Time Frame: maximum 7 days before surgery until conclusion of surgery ]
Secondary Outcome Measures:
- Numbers of colony forming units (CFUs) found on solid media. Specimens were cultured aerobically and micro-aerobically on blood agar plates and anaerobically on chocolate agar plates and CFUs were determined on each plate using a magnifying glass. [ Time Frame: maximum 7 days before surgery until concluison of surgery ]
| Enrollment: | 140 |
| Study Start Date: | September 2004 |
| Study Completion Date: | April 2005 |
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Patients undergoing surgery for cataract, glaucoma or vitrectomy
Exclusion Criteria:
- Patients who report to be allergic to levofloxacin or iodine
- Patients on topical antibiotic within the last 30 days
- Patients with acute conjunctivitis, blepharitis or dacryocystitis
- Patients under age of 18 years
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00491049
Locations
| Germany | |
| Augenklinik der LMU | |
| Munich, Bavaria, Germany, 80336 | |
Sponsors and Collaborators
Ludwig-Maximilians - University of Munich
Santen Gmbh
Investigators
| Principal Investigator: | Herminia Mino de Kapsar, PhD | Augenklinik der LMU |
More Information
Additional Information:
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| ClinicalTrials.gov Identifier: | NCT00491049 History of Changes |
| Other Study ID Numbers: | LevoProMUC03 |
| Study First Received: | June 21, 2007 |
| Last Updated: | June 21, 2007 |
| Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
Keywords provided by Ludwig-Maximilians - University of Munich:
|
prophylaxis intraocular surgery endophthalmitis antibiotic |
Additional relevant MeSH terms:
|
Ofloxacin Anti-Bacterial Agents Anti-Infective Agents Therapeutic Uses Pharmacologic Actions |
Nucleic Acid Synthesis Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Anti-Infective Agents, Urinary Renal Agents |
ClinicalTrials.gov processed this record on June 18, 2013